NL-OMON39889已完成不适用
Dynamic Changes in Bone Marrow Adiposity and the Role of Estrogen - Estrogen and changes in bone marrow adiposity
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •regular menstrual cycle and age 18 to 50 years OR 1-5 years postmenopausal
排除标准
- •contraindications to MRI scanning
- •use of bone-modifying or adipose tissue-modifying drugs
- •use of hormonal contraception
- •bone/adipose tissue/bone marrow diseases
- •contraindications to estrogen treatment (history of hormone-sensitive cancer, VTE, unexplained vaginal bleeding, endometrial hyperplasia, endometriosis, arterial thrombo-embolic diseases, acute hepatic disease or liver enzyme disorders, porfyria or known hypersensitivity to components of zumenon)
研究者
相似试验
已完成
不适用
Estrogen and bone marrow adiposity.OsteoporosisNL-OMON21671Academic Medical Center (AMC) Amsterdam6
已完成
不适用
The Effects of Acute Weight Gain and Acute Calorie Deprivation on Marrow Adipose TissueHealthyNCT02482519Massachusetts General Hospital28
尚未招募
不适用
Stem cell- based therapy in Asherman syndromeCondition 1: Asherman Syndrome. Condition 2: Endometrial Atrophy.Female infertility of uterine originIRCT20190306042948N1Hamedan University of Medical Sciences10
进行中（未招募）
1 期
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody.An investigator-led, industry supported, multicentre, open-label, single treatment arm, prospective clinical trial. - Effects of B cell depletion on bone turnover in rheumatoid arthritis.rheumatoid arthritisEUCTR2010-020499-50-GBSouth Tees Hospitals NHS Foundation Trust46
已完成
不适用
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting antibodyRheumatoid arthritisISRCTN82317088South Tees Hospitals NHS Foundation Trust (UK)46